autologous bone marrow derived stem cells (retinal diseases, University of Sao Paulo)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug Nameautologous bone marrow derived stem cells (retinal diseases, University of Sao Paulo)

Drug Alias Nameautologous bone marrow derived stem cells (retinal diseases)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsRetinitis Pigmentosa

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBrazil

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of São Paulo

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity of Sao Paulo

Active IndicationsN/A

Inactive IndicationsRetinitis Pigmentosa

Other Information

ATC CodeN/A